Rachel King

(Ms. Rachel King)

Currently holds positions in Novavax Inc and GlycoMimetics Inc

Positions

Position Company Period
Independent Director Novavax Inc Nov. 1, 2018 -
President, Chief Executive Officer, Co-Founder, Director GlycoMimetics Inc Jan. 1, 2003 -
Rachel King's trades of Novavax Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-02 2024-12-13
US Novavax Inc (NVAX)
S Sale
4,150 -21.9%
9.02
USD 37,435 		4,150 -21.9% 9.02 USD 37,435
2021-05-21 2021-05-19
US Novavax Inc (NVAX)
B Purchase
700 +33.3%
139.64
USD 97,748 		700 +33.3% 139.64 USD 97,748
2020-12-30 2020-12-28
PS Planned sale
84,176 -19.1%
3.91
USD 329,128 		84,176 -19.1% 3.91 USD 329,128
2019-03-28 2019-03-27
US Novavax Inc (NVAX)
B Purchase
22,000 +inf%
0.53
USD 11,656 		22,000 +inf% 0.53 USD 11,656
2019-03-28 2019-03-27
US Novavax Inc (NVAX)
B Purchase
22,000 +inf%
0.53
USD 11,656 		22,000 +inf% 0.53 USD 11,656
2019-03-28 2019-03-27
US Novavax Inc (NVAX)
B Purchase
42,000 +inf%
0.53
USD 22,252 		42,000 +inf% 0.53 USD 22,252
// ... existing code ... // ... rest of the file ...